Skip to main content
AddLife logo

AddLife — Investor Relations & Filings

Ticker · ALIF ISIN · SE0014401378 LEI · 5493005T3M7CD7XWE013 ST Wholesale and retail trade
Open in API
Filings indexed 294 across all filing types
Latest filing 2019-07-15 Major Shareholding Noti…
Country SE Sweden
Listing ST ALIF

About AddLife

https://www.add.life/

AddLife is a life science group that operates through a decentralized model, acquiring and developing market-leading companies in niche segments. The group consists of numerous independent subsidiaries that provide specialized products, services, and advisory support primarily to the healthcare and research sectors. Its offerings encompass a broad range of instruments, equipment, consumables, and advanced solutions for diagnostics, medical technology, and biomedical research and laboratory analysis. AddLife's business strategy focuses on combining the strength and resources of a large enterprise with the entrepreneurial drive and agility of its subsidiaries, fostering growth and innovation while preserving the unique culture of each acquired company.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding for ODIN Forvaltning AS in AddLife AB. It explicitly states 'Reason for major shareholding notification Buy' and provides 'Before the transaction' and 'After the transaction' figures, including the resulting percentage of voting rights (6.67386 %). This structure is characteristic of a notification regarding a change in significant ownership thresholds, which corresponds to the Major Shareholding Notification category.
2019-07-15 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period 1 January – 30 June 2019. It contains comprehensive financial statements, including income statements, balance sheet data, segment reporting (Labtech and Medtech), and management commentary on business performance. It is clearly a substantive financial report for a period shorter than a full fiscal year, not an announcement or a certification. H1 2019
2019-07-12 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT 1 JANUARY – 30 JUNE 2019' and contains detailed financial statements, including net sales, EBITA, profit after tax, and cash flow for the 3-month and 6-month periods ending June 30, 2019. It also includes management commentary, business area analysis (Labtech and Medtech), and comparative tables. This meets the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2019
2019-07-12 English
Share-based incentive scheme
Remuneration Information Classification · 99% confidence The document discusses the details of a share-based incentive scheme involving call options on repurchased class B shares, including transfer prices, redemption prices, and exercise periods. This relates directly to the company's capital structure, financing, or equity compensation plans. It is not a full annual report (10-K), an earnings release (ER), or a standard dividend notice (DIV). It specifically details the terms of an incentive scheme approved at the AGM, which falls under changes to capital structure or financing activities. The closest fit among the provided definitions is 'Capital/Financing Update' (CAP), as it details the terms of issuing options tied to shares, which is a form of capital management/financing activity. It is not a Director's Dealing (DIRS) as it concerns management options, not personal trades, and it is not a Remuneration Report (DEF 14A) which focuses on executive compensation disclosure.
2019-06-04 English
Aktierelaterat incitamentsprogram
Remuneration Information Classification · 99% confidence The document discusses an incentive program involving stock options ('köpoptioner') approved by the Annual General Meeting ('avårsstämman'). It details the terms of these options, including the number of options, exercise price, and vesting period. This content directly relates to capital structure changes, share-based compensation, or financing activities approved by shareholders. Given the specific focus on the execution and terms of a stock option program, the most fitting category is 'Capital/Financing Update' (CAP), as it details the issuance/terms of equity-linked instruments. While it relates to remuneration, the structure is more about the capital instrument itself than just executive pay disclosure (DEF 14A). It is not a general earnings release (ER) or a full annual report (10-K). Since it details the terms of an equity instrument being executed, CAP is the best fit.
2019-06-04 Swedish
Annual General Meeting of AddLife AB 9 May 2019
AGM Information Classification · 99% confidence The document explicitly states it contains the 'Resolutions' passed by the 'Annual General Meeting ("AGM")' held on May 9, 2019. It details specific resolutions regarding dividends, discharge from liability, election of directors and auditors, remuneration, and authorizations for share issuance/repurchase. This content is the core output of an AGM, making the classification 'AGM Information' (AGM-R) the most appropriate fit, as opposed to a proxy statement (PSI) or a general regulatory filing (RNS). The document length (7434 chars) is substantial enough to be the primary record of the meeting's outcomes.
2019-05-09 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.